Filing Flows › Comparisons › LAKE vs SMTI
Lakeland Industries vs Sanara MedTech: LAKE and SMTI compared
Lakeland Industries is the larger company: $50.1M of revenue in its latest quarter (Q2 FY27) against $28.1M for Sanara MedTech (Q2 2026). Sanara MedTech is growing faster (+9% against -4% a year earlier). Sanara MedTech is more profitable, with an operating margin of 6.3% against -6.7%.
Where the money goes: LAKE and SMTI
Lakeland Industries (LAKE) · Q2 FY27
Lakeland Industries, Q2 FY27: revenue $50.1M (-4% year over year), operating margin -6.7%, net loss $4.9M, operating cash flow −$404K. The chart follows the revenue to costs, profit and cash.
Sanara MedTech (SMTI) · Q2 2026
Sanara MedTech, Q2 2026: revenue $28.1M (+9% year over year), operating margin 6.3%, net loss $453K, operating cash flow $2.0M. The chart follows the revenue to costs, profit and cash.
| Lakeland Industries (LAKE) | Sanara MedTech (SMTI) | |
|---|---|---|
| Latest quarter | Q2 FY27 | Q2 2026 |
| Revenue | $50.1M | $28.1M |
| Revenue growth, Y/Y | -4% | +9% |
| Operating margin | -6.7% | 6.3% |
| Net earnings | −$4.9M | −$453K |
| Net margin | -9.8% | -1.6% |
| Operating cash flow | −$404K | $2.0M |
| Free cash flow | — | $2.0M |
| Market value | — | $304M |
| P/E | — | 7.0× |
| Analysts’ mean target | — | $35.00 |
Where the revenue comes from
Sanara MedTech
- Soft Tissue Repair Products: $25.2M (90%)
- Bone Fusion Products: $2.9M (10%)
Questions
Which is bigger, Lakeland Industries or Sanara MedTech?
Lakeland Industries is the larger company: $50.1M of revenue in its latest quarter (Q2 FY27) against $28.1M for Sanara MedTech (Q2 2026).
Is Lakeland Industries or Sanara MedTech growing faster?
Sanara MedTech is growing faster (+9% against -4% a year earlier).
Which is more profitable, Lakeland Industries or Sanara MedTech?
Sanara MedTech is more profitable, with an operating margin of 6.3% against -6.7%.
More: Lakeland Industries earnings · how Lakeland Industries makes money · Sanara MedTech earnings · how Sanara MedTech makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Sep 9, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.